Clinical Trial

Concurrent Vestibular Activation and Postural Training Using Virtual Reality

Study acronym: VR-HS-WST
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Postural instability is a common symptom of vestibular dysfunction that impacts a person's day-to-day activities. Vestibular rehabilitation is effective in decreasing dizziness, visual symptoms and improving postural control through several mechanisms including sensory reweighting. As part of the sensory reweighting mechanisms, vestibular activation training with headshake activities influence vestibular reflexes. However, combining challenging vestibular and postural tasks to facilitate more effective rehabilitation outcomes is under-utilized. The novel concurrent headshake and weight shift training (Concurrent HS-WST) is purported to train the vestibular system to directly impact the postural control system simultaneously and engage sensory reweighting to improve balance. Healthy older adults will perform the training by donning a virtual reality headset and standing on the floor or foam pad with an overhead harness on and a spotter present to prevent any falls. The investigators propose that this training strategy would show improved outcomes over traditional training methods by improving vestibular-ocular reflex (VOR) gains, eye movement variability, sensory reweighting and promoting postural balance. The findings of this study may guide clinicians to develop rehabilitation methods for vestibular postural control in neurological populations with vestibular and/or sensorimotor control impairment.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-07-10; most recent amendment 2026-06-05.
Status change: Active, Not Recruiting → Completed 2026-04-15
Status change: Recruiting → Active, Not Recruiting 2025-06-15
Status change: Not Yet Recruiting → Recruiting 2024-05-07
Trial Details
NCT Number NCT05942781
Lead Sponsor Clarkson University
Conditions Vestibular Disorder
Enrollment 24 participants
Start Date 2024-04-15
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-18